| 000 | 01172 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514022606.0 | ||
| 264 | 0 | _c20020207 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a0160-6689 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHenderson, D C | |
| 245 | 0 | 0 |
_aClinical experience with insulin resistance, diabetic ketoacidosis, and type 2 diabetes mellitus in patients treated with atypical antipsychotic agents. _h[electronic resource] |
| 260 |
_bThe Journal of clinical psychiatry _c2001 |
||
| 300 |
_a10-4; discussion 40-1 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xchemically induced |
| 650 | 0 | 4 |
_aDiabetic Ketoacidosis _xchemically induced |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPsychotic Disorders _xdrug therapy |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 773 | 0 |
_tThe Journal of clinical psychiatry _gvol. 62 Suppl 27 _gp. 10-4; discussion 40-1 |
|
| 999 |
_c11717176 _d11717176 |
||